PRINTO (the Paediatric Rheumatology International Trials Organisation)

Institute of Child Health

Overview

A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months

Study Type

OBSERVATIONAL

Sex: ALLMax age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Any child with JIA who has gone into remission using methotrexate

Rheumatology ICH

London, United Kingdom

RECRUITING

Lucy Wedderburn, Dr

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.